TACE / TARE for Liver Cancer Treatment

Transarterial Chemoembolization (TACE) and Transarterial Radioembolization (TARE) are minimally invasive procedures used to treat liver cancer, particularly hepatocellular carcinoma (HCC). These procedures are designed to target liver tumors directly by delivering chemotherapy or radiation through the blood vessels that supply the tumor, improving local control of the disease while minimizing damage to healthy liver tissue.

What Is TACE?

Transarterial Chemoembolization (TACE) involves the delivery of chemotherapy drugs directly to the tumor through the hepatic artery, the main blood supply to the liver. Once the chemotherapy is delivered, embolic agents (small particles) are used to block the blood supply to the tumor. This causes the tumor to starve and shrink while the chemotherapy continues to attack the cancer cells.

What Is TARE?

Transarterial Radioembolization (TARE) is similar to TACE, but instead of chemotherapy, it uses small radioactive beads (Yttrium-90 or Y-90) that are delivered through the hepatic artery into the tumor. These beads emit targeted radiation directly to the tumor, which destroys cancer cells while minimizing exposure to healthy tissue in the liver.

Why These Procedures Are Done:

• For liver cancer treatment: Both TACE and TARE are primarily used to treat liver cancer, particularly in patients who cannot undergo surgery or are ineligible for a liver transplant.
• To control tumor growth: These procedures are used to shrink tumors, reduce symptoms, and control the spread of liver cancer, especially when the tumor is confined to one or both lobes of the liver.
• In combination with other treatments: TACE and TARE may be used in combination with surgery, chemotherapy, or liver transplant to improve overall outcomes for patients with liver cancer.
• For symptomatic relief: These treatments can help alleviate symptoms such as pain, nausea, or jaundice caused by liver tumors.

How TACE Works:

1. Preparation: The patient is given local anesthesia and sedation. A catheter is inserted into the femoral artery (in the groin), and it is guided to the hepatic artery using imaging (such as X-ray or fluoroscopy).
2. Procedure: The chemotherapy drugs and embolic particles are delivered directly to the tumor via the catheter. The embolization blocks the tumor’s blood supply, causing it to shrink and preventing it from receiving nutrients, while the chemotherapy drugs target the cancer cells.
3. Post-procedure: The patient is monitored for a short period, and many can go home the same day or after a brief hospital stay. Side effects such as mild pain or fever may occur after the procedure, but these typically resolve within a few days.

How TARE Works:

1. Preparation: Similar to TACE, the patient is given local anesthesia and sedation. A catheter is inserted into the femoral artery and guided to the hepatic artery supplying the tumor.
2. Procedure: Instead of chemotherapy, small radioactive Y-90 beads are injected into the tumor via the catheter. The beads release targeted radiation that directly destroys cancer cells.
3. Post-procedure: TARE is typically well-tolerated, and patients are monitored for any side effects, which can include mild fatigue or fever. Recovery time is generally quick, and patients may be discharged the same day or the next.

Benefits of TACE and TARE:

• Targeted treatment: Both procedures directly target the tumor, minimizing damage to healthy liver tissue and other organs.
• Minimally invasive: TACE and TARE are performed through small incisions, meaning less risk and faster recovery compared to traditional surgery.
• Effective for inoperable tumors: These treatments offer an option for patients who are not candidates for surgery, such as those with large or multiple tumors or underlying liver disease.
• Control and symptom relief: Both procedures help control the growth of the tumor and reduce symptoms associated with liver cancer, improving quality of life.
• Can be used alongside other treatments: TACE and TARE can complement other therapies such as surgery, systemic chemotherapy, or liver transplant, enhancing the overall treatment plan.